![Lars Damstrup](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lars Damstrup
Direttore Tecnico/Scientifico/R&S presso SCANDION ONCOLOGY A/S
Profilo
Lars Damstrup is currently the Chief Medical Officer at Scandion Oncology A.
Previously, he worked as a Senior Medical Director at Symphogen A and Merck Serono GmbH.
Dr. Damstrup holds a doctorate degree from the University of Copenhagen.
Posizioni attive di Lars Damstrup
Società | Posizione | Inizio |
---|---|---|
SCANDION ONCOLOGY A/S | Direttore Tecnico/Scientifico/R&S | 01/01/2023 |
Precedenti posizioni note di Lars Damstrup
Società | Posizione | Fine |
---|---|---|
Symphogen A/S
![]() Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Direttore Tecnico/Scientifico/R&S | - |
Merck Serono GmbH
![]() Merck Serono GmbH Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Merck Serono GmbH is a German pharmaceutical company that manufactures and distributes pharmaceutical products. The company is based in Darmstadt, Germany. The CEOs of the company are Matthias Pfannkuche, Angelika Heinl, Sören Hermansson. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Lars Damstrup
University of Copenhagen | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
SCANDION ONCOLOGY A/S | Health Technology |
Aziende private | 2 |
---|---|
Merck Serono GmbH
![]() Merck Serono GmbH Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Merck Serono GmbH is a German pharmaceutical company that manufactures and distributes pharmaceutical products. The company is based in Darmstadt, Germany. The CEOs of the company are Matthias Pfannkuche, Angelika Heinl, Sören Hermansson. | Health Technology |
Symphogen A/S
![]() Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Health Technology |
- Borsa valori
- Insiders
- Lars Damstrup